Medingenii Capital

About The Fund

Medingenii Capital is a venture capital firm based in Houston, Texas with a strategic focus on early-stage investments in the medical, healthcare, femtech, and life science industries. They are highly sought after for their domain expertise, ability to scale businesses, and their expansive global resource network. The firm is composed of a diverse team of physicians and entrepreneurs dedicated to advancing healthcare by fostering companies with innovative products and technology. A key aspect of their strategy involves leveraging their involvement in the Texas Medical Center ecosystem and their worldwide network of investors, business operators, and talent sources to scale companies, accelerate growth, and achieve significant investment exits. They operate with a competitive edge through a global deal flow and a history of multiple investment exits, emphasizing tech-focused medical, healthcare, and life science ventures. Medingenii Capital's investment focus includes healthcare information technology, genomic testing, patient engagement, and medical devices. Their team consists of General Partners Gen Fukunaga, Greg Campbell, Diane Yoo, Eddie Patton, and Sreedhar Mandayam, each bringing unique skills and experiences, enhancing the firm's investment acumen and operational excellence. Medingenii Capital champions innovation by mentoring companies and creating angel networks, which further solidifies their commitment to nurturing promising ventures and contributing to the world's largest life science destination.